KAREN DEVORE, MD
Dermatology Physician in SPARTANBURG, South Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KAREN DEVORE, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 1,509 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KAREN DEVORE, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
KAREN DEVORE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
KAREN DEVORE, MD at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in South Carolina
How Dermatology Physician compares to other specialties among South Carolina providers
Dermatology Physician share within South Carolina
Dermatology Physician is one of the more visible NUCC categories in South Carolina
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KAREN DEVORE, MD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Dermatology Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KAREN DEVORE, MD is a Dermatology Physician provider practicing in SPARTANBURG, South Carolina, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1821098823. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
KAREN DEVORE, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 490 FLOYD RD, SPARTANBURG, SC, 29307, with a listed phone of (864) 596-7546. NPI 1821098823 was issued on 08/01/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEVORE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,509 prescription claims written by this provider, covering 601 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1821098823 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 08/01/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KAREN DEVORE, MD's current license status, disciplinary history, and board certifications with the South Carolina Board of Medical Examiners in South Carolina before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KAREN DEVORE, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.6K
Largest payer
Janssen Biotech, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 1,509 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,834
- Total Day Supply
- 48,657
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $1.8M
- Generic Drug Cost
- $35K
- Antibiotic Claims
- 162
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 43, 65-74: 259, 75-84: 227, 85+: 72
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 212 |
| Triamcinolone Acetonide | 206 |
| Fluticasone Propionate | 117 |
| Ketoconazole | 66 |
| Hydroxychloroquine Sulfate | 65 |
| Minocycline Hcl | 64 |
| Clobetasol Propionate | 58 |
| Valacyclovir Valacyclovir Hcl | 45 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 42 |
| Humira(Cf) Pen Adalimumab | 32 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How KAREN DEVORE, MD fits within the Dermatology Physician landscape nationally.
KAREN DEVORE, MD's 1,509 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in South Carolina
Other clinicians with the same primary specialty enrolled in South Carolina, drawn from the same CMS NPPES roster as DEVORE.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore South Carolina
Frequently Asked Questions
What is KAREN DEVORE, MD's specialty? ▼
How much does KAREN DEVORE, MD prescribe under Medicare Part D? ▼
What is KAREN DEVORE, MD's Medicare quality score? ▼
Where is KAREN DEVORE, MD located? ▼
What is KAREN DEVORE, MD's NPI number? ▼
Does KAREN DEVORE, MD prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does KAREN DEVORE, MD prescribe most often? ▼
Does KAREN DEVORE, MD accept Medicare? ▼
How can I verify KAREN DEVORE, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology